2026-09-20T03:28:46Zhttps://dspace.mit.edu/server/oai/request

oai:dspace.mit.edu:1721.1/1230602026-06-16T18:15:04Zcom_1721.1_7582com_1721.1_7581col_1721.1_131022

Angela N. Koehler. Chen, Andrew,Ph.D.Massachusetts Institute of Technology. Massachusetts Institute of Technology. Department of Biological Engineering. Massachusetts Institute of Technology. Department of Biological Engineering 2019-11-22T00:08:59Z 2019-11-22T00:08:59Z 2019 2019 https://hdl.handle.net/1721.1/123060 1127290924 Thesis: Ph. D., Massachusetts Institute of Technology, Department of Biological Engineering, 2019 Cataloged from PDF version of thesis. Includes bibliographical references (pages 190-200). The transcription factor Myc is a basic helix-loop-helix leucine zipper (bHLHLZ) protein with crucial roles in regulating normal cellular processes, but its transcriptional activity is deregulated in a majority of human cancers. Myc transcriptional activity is dependent on dimerization with its obligate partner Max, another bHLHLZ transcription factor. Max also forms homodimers as well as heterodimers with other proteins including the Mxd family of proteins, creating a dynamic network of protein-protein interactions to regulate transcriptional programs. Despite the significance of this network, the arsenal of chemical probes to interrogate these proteins in cancer biology remains limited. Here, we utilized small molecule microarrays and luciferase-based reporter assays to identify compounds that bind Max and modulate Myc transcriptional activity. We discovered the small molecule KI-MS2-008, which stabilizes the Max homodimer while reducing Myc protein and Myc-regulated transcript levels. KI-MS2-008 also decreases viable cancer cell growth in a Myc-dependent manner and suppresses tumor growth in mouse models of Myc-driven cancers. In a cancer cell line model treated with KI-MS2-008, the equilibrium of protein-protein interactions shifts toward a transcriptionally repressed state over time by recruiting Mxd4 and other repressive machinery to Max. This study establishes that perturbing Max dimerization with small molecules is a tractable approach to targeting Myc activity in cancer. by Andrew Chen. Ph.D. Ph.D. Massachusetts Institute of Technology, Department of Biological Engineering 200 pages eng Massachusetts Institute of Technology MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission. http://dspace.mit.edu/handle/1721.1/7582 Biological Engineering. Discovery and characterization of a small molecule that modulates c-Myc mediated transcription via max homodimer stabilization Thesis application/pdf 2019-11-22T00:08:58Z Publication Doctoral BioEng unknown unknown <Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="fc8d2f15-6d45-4f74-a552-201d8c5dc8b8"> <Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type> <Language>eng</Language> <Title>Discovery and characterization of a small molecule that modulates c-Myc mediated transcription via max homodimer stabilization</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2019</PublicationDate> <Authors> <Author> <DisplayName>Chen, Andrew,Ph.D.Massachusetts Institute of Technology.</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <DisplayName>Massachusetts Institute of Technology</DisplayName> <OrgUnit /> </Publisher> </Publishers> <License>http://dspace.mit.edu/handle/1721.1/7582</License> <Keyword>Biological Engineering.</Keyword> <Abstract>The transcription factor Myc is a basic helix-loop-helix leucine zipper (bHLHLZ) protein with crucial roles in regulating normal cellular processes, but its transcriptional activity is deregulated in a majority of human cancers. Myc transcriptional activity is dependent on dimerization with its obligate partner Max, another bHLHLZ transcription factor. Max also forms homodimers as well as heterodimers with other proteins including the Mxd family of proteins, creating a dynamic network of protein-protein interactions to regulate transcriptional programs. Despite the significance of this network, the arsenal of chemical probes to interrogate these proteins in cancer biology remains limited. Here, we utilized small molecule microarrays and luciferase-based reporter assays to identify compounds that bind Max and modulate Myc transcriptional activity. We discovered the small molecule KI-MS2-008, which stabilizes the Max homodimer while reducing Myc protein and Myc-regulated transcript levels. KI-MS2-008 also decreases viable cancer cell growth in a Myc-dependent manner and suppresses tumor growth in mouse models of Myc-driven cancers. In a cancer cell line model treated with KI-MS2-008, the equilibrium of protein-protein interactions shifts toward a transcriptionally repressed state over time by recruiting Mxd4 and other repressive machinery to Max. This study establishes that perturbing Max dimerization with small molecules is a tractable approach to targeting Myc activity in cancer.</Abstract> <Access xmlns="http://purl.org/coar/access_right" > </Access> </Publication>